SBDS Human

Shwachman-Bodian-Diamond Syndrome Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to SBDS Human

SBDS Human (Shwachman-Bodian-Diamond syndrome protein) is a ribosome maturation protein encoded by the SBDS gene (OMIM: 607444) located on chromosome 7q11.22 . This 30.9 kDa protein is critical for the biogenesis of the 60S ribosomal subunit and is associated with Shwachman-Diamond syndrome (SDS), a rare autosomal recessive disorder characterized by bone marrow failure, pancreatic insufficiency, and skeletal abnormalities .

Ribosome Maturation

SBDS collaborates with elongation factor-like GTPase 1 (EFL1) to remove eIF6 from the 60S ribosomal subunit, enabling subunit joining and translation initiation .

ProcessMechanismExperimental Evidence
eIF6 DisplacementSBDS + EFL1 + GTP hydrolysis → eIF6 releaseMouse models, ribosomal profiling
Ribosomal RNA (rRNA)Binds 28S rRNA; coprecipitates with 60S subunitsSucrose gradient centrifugation

Apoptosis Regulation

SBDS deficiency increases Fas receptor expression, sensitizing cells to apoptosis via caspase-8 activation .

ObservationMechanismModel System
Accelerated Apoptosis↑ Fas ligand sensitivity, ↓ cell survivalHeLa/shSBDS knockdown

Metabolic and Translational Effects

SBDS loss reduces global protein synthesis and alters cellular metabolism:

PhenotypeMechanismSource
↓ ATP, ↑ LysosomalTranslational inefficiency, compensatory catabolismMouse fibroblasts
↓ Oncogenic TransformationImpaired ribosome maturation limits growthImmortalized Sbds mutant cells

Shwachman-Diamond Syndrome (SDS)

MutationTypeEffectFrequency
c.258+2T>CSplice-site variantDisrupts mRNA splicing; no functional protein~62% of SDS patients
c.183_184TA>CTFrameshiftPremature termination codon~90% of SDS patients
c.201A>GMissenseAltered protein function~1% of carriers

Pathogenic Mechanism:

  • Gene Conversion: SBDS mutations arise from recombination with its pseudogene SBDSP1 .

  • Hypomorphic Alleles: Most SDS patients retain partial SBDS function, as complete loss is embryonically lethal .

Experimental Models

ModelKey FindingsSource
ZebrafishPancreatic atrophy, neutropenia; p53 pathway modulation rescues defects
Mouse Fibroblasts↓ Colony formation, ↑ stress sensitivity

Research and Clinical Applications

  • Diagnostic Challenges: Misalignment of NGS reads with SBDSP1 complicates variant detection; novel read-depth methods improve accuracy .

  • Therapeutic Targets: Enhancing translational efficiency or modulating the lysosomal pathway may mitigate SDS phenotypes .

Product Specs

Introduction
The SBDS protein plays a crucial role in ribosome biogenesis and translational activation. It is highly conserved across various species, highlighting its importance in cellular function. Mutations in the SBDS gene lead to Shwachman-Diamond syndrome, a rare genetic disorder.
Description
This product consists of the recombinant human SBDS protein, expressed in E. coli and purified to a high degree. It is a single, non-glycosylated polypeptide chain comprising 270 amino acids (residues 1-250) with a molecular weight of 30.9 kDa. For purification purposes, a 20 amino acid His-tag is present at the N-terminus.
Physical Appearance
Clear, colorless and sterile-filtered solution.
Formulation
The SBDS protein is supplied at a concentration of 0.5 mg/mL in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 2 mM DTT, 50 mM NaCl, 0.1 mM EDTA, and 20% glycerol.
Purity
The purity of the SBDS protein is greater than 95% as determined by SDS-PAGE analysis.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the protein at -20°C. Avoid repeated freeze-thaw cycles to maintain protein stability.
Synonyms
SDS, SWDS, Shwachman-Bodian-Diamond syndrome, Ribosome Maturation protein SBDS.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MSIFTPTNQI RLTNVAVVRM KRAGKRFEIA CYKNKVVGWR SGVEKDLDEV LQTHSVFVNV SKGQVAKKED LISAFGTDDQ TEICKQILTK GEVQVSDKER HTQLEQMFRD IATIVADKCV NPETKRPYTV ILIERAMKDI HYSVKTNKST KQQALEVIKQ LKEKMKIERA HMRLRFILPV NEGKKLKEKL KPLIKVIESE DYGQQLEIVC LIDPGCFREI DELIKKETKG KGSLEVLNLK DVEEGDEKFE

Q&A

What is the SBDS gene and what is its normal function in human cells?

The SBDS gene provides instructions for making a protein that plays a critical role in ribosome biogenesis. Specifically, the SBDS protein helps prepare the large ribosomal subunit by facilitating the removal of the eIF6 protein, which blocks the interaction between the large and small subunits necessary for ribosome assembly . Research has revealed that SBDS functions extend beyond ribosome biogenesis to include roles in cell division, cellular movement, stress protection, and RNA processing . The gene is located on human chromosome 7q11, and its expression is essential for normal cellular function across multiple tissues .

How is SBDS associated with Shwachman-Diamond syndrome?

Shwachman-Diamond syndrome (SDS) is an autosomal recessive genetic disorder with pleiotropic phenotypes including exocrine pancreatic insufficiency, bone marrow dysfunction, neutropenia, and skeletal abnormalities . Approximately 90% of SDS patients have biallelic pathogenic variants in the SBDS gene . Over 80 different mutations in the SBDS gene have been identified in SDS patients . Many of these mutations result from gene conversion events with a nearby pseudogene on chromosome 7 . Importantly, studies in mice indicate that complete absence of SBDS expression is lethal, suggesting that SDS patients typically harbor at least one hypomorphic SBDS allele rather than complete loss of function .

What is the structure of the human SBDS protein?

The solution structure of human SBDS protein has been determined using NMR spectroscopy. Similar to archaeal SBDS orthologs, the human SBDS comprises three well-folded domains :

  • N-terminal FYSH (fungal, Yhr087wp, Shwachman) domain

  • Central domain

  • C-terminal domain

A notable structural feature is the flexible linker between the N-terminal and central domains, which exhibits significant conformational exchange in NMR dynamics experiments . This flexibility likely facilitates the relative motions between domains that may be important for SBDS function. The N-terminal FYSH domain contains a classic RNA binding site and harbors most of the mutations described for human SBDS .

What experimental models are most effective for studying SBDS function?

Several experimental models have proven valuable for studying SBDS function:

Model SystemAdvantagesLimitationsKey Applications
SDS patient-derived cellsDirect clinical relevanceGenetic variability between patientsDisease mechanism studies
SBDS-depleted cell lines (e.g., HEK293)Controlled genetic backgroundMay not recapitulate tissue-specific effectsBiochemical and molecular studies
Yeast models (Sdo1)Genetically tractableEvolutionary distance from humansBasic conserved functions
Lentiviral complementation systemsAllows rescue experimentsPotential for overexpression artifactsFunctional validation

Patient-derived cell lines have been essential for understanding disease pathogenesis. For example, SDS patient cells show hypersensitivity to actinomycin D, which can be corrected by lentiviral transduction of wild-type SBDS, confirming that this phenotype is SBDS-dependent . The use of SBDS-depleted HEK293 cells has revealed cellular hypersensitivity to various types of DNA damage and ER stress .

How does SBDS contribute to ribosome biogenesis and protein translation?

SBDS plays a crucial role in the maturation of 60S ribosomal subunits, specifically in the cytoplasmic maturation phase of ribosome biogenesis. The protein helps remove the anti-association factor eIF6 from the pre-60S ribosomal subunit, which is necessary for the joining of the 60S and 40S subunits to form the functional 80S ribosome .

Functional studies have established that:

  • SBDS interacts with several ribosomal proteins, particularly of the large subunit (e.g., RPL4)

  • SBDS depletion impairs protein translation capability in human cells

  • The yeast ortholog Sdo1 has an established role in 60S ribosomal subunit maturation

The connection between SBDS and ribosome biogenesis is further supported by its nucleolar enrichment and the co-clustering of SBDS with other genes involved in RNA metabolism or translation .

What is the relationship between SBDS and DNA damage response mechanisms?

SBDS plays a significant role in DNA metabolism and damage response that appears distinct from its function in translation:

  • Proteomic studies have identified SBDS interactions with proteins involved in DNA metabolism

  • SBDS-depleted HEK293 cells show hypersensitivity to multiple types of DNA damage

  • The DNA damage hypersensitivity phenotype can be distinguished from SBDS's role in translation through experiments using multiple methods to impair global translation

These findings suggest that SBDS has a direct role in DNA damage response pathways, which may contribute to the increased risk of myelodysplasia and leukemia observed in SDS patients. The specific molecular mechanisms involved remain an active area of investigation.

What techniques can be used to analyze SBDS-RNA interactions and specificity?

Several techniques have been employed to characterize SBDS-RNA interactions:

  • NMR spectroscopy with heteronuclear correlation experiments and chemical shift mapping has identified a classic RNA binding site at the N-terminal FYSH domain

  • Affinity capture methods coupled with mass spectrometry have been used to identify SBDS-interacting proteins, including those involved in RNA metabolism

  • Co-immunoprecipitation experiments with endogenous SBDS can validate interactions with specific RNA-binding proteins

Understanding the RNA binding specificity of SBDS remains challenging. While RNA-binding activity has been predicted for archaeal and yeast SBDS orthologs, the full-length SBDS orthologs function in a species-specific manner . This indicates that knowledge obtained from model systems may have limitations when applied to human SBDS, underscoring the importance of studying RNA interactions using human SBDS protein.

What are the known protein interactions of SBDS and how do they relate to its multiple functions?

Affinity capture combined with mass spectrometry has identified numerous SBDS-interacting proteins, revealing a complex interactome that supports diverse biological functions . Notable interactions include:

  • Ribosomal proteins (e.g., RPL4) - supporting its role in ribosome biogenesis

  • Proteins involved in DNA metabolism - consistent with its function in DNA damage response

  • RNA processing factors - aligning with its RNA-binding capabilities

The SBDS interactome shows an enrichment of ribosomal proteins and proteins involved in DNA metabolism, which correlates with the experimentally observed functions of SBDS in translation and DNA damage response . These interactions provide a foundation for understanding the molecular mechanisms underlying the various cellular functions of SBDS.

What methodological approaches can detect and quantify SBDS expression and activity?

Researchers can employ several methods to detect and quantify SBDS expression and activity:

MethodApplicationAdvantagesConsiderations
ImmunoblottingProtein expressionQuantitative, detects endogenous proteinRequires specific antibodies
ImmunoprecipitationProtein interactionsCaptures native complexesMay miss transient interactions
Lentiviral complementationFunctional rescueConfirms causalityExpression level control needed
Cellular sensitivity assaysFunctional assessmentMeasures physiological responsesIndirect measurement of activity
NMR spectroscopyStructural analysisHigh-resolution protein dynamicsRequires purified protein
Mass spectrometryInteractome analysisUnbiased, comprehensiveRequires validation of hits

For example, SBDS protein expression in patient cells and complemented cell lines can be confirmed by immunoblotting using specific antibodies (e.g., α-N-SBDS, α-M-SBDS) . Functional complementation can be assessed through restoration of SBDS expression following lentiviral transduction of the SBDS cDNA and subsequent testing for correction of cellular phenotypes, such as actinomycin D hypersensitivity .

How can researchers distinguish between the different roles of SBDS in various cellular processes?

Distinguishing between the multiple functions of SBDS presents a significant challenge. Several approaches can help researchers separate these functions:

  • Domain-specific mutations: Introducing mutations that affect specific domains of SBDS can help isolate functions associated with those domains

  • Cellular stress paradigms: Using specific stressors (e.g., UV irradiation, ER stress inducers) can help isolate particular SBDS functions

  • Translation inhibitors: Comparing the effects of SBDS depletion with chemical translation inhibitors can distinguish translation-dependent from translation-independent functions

  • Structure-function analysis: Correlating the protein's structural domains with specific cellular functions through targeted mutations

  • Cross-complementation experiments: Testing if SBDS orthologs from different species can rescue specific functions in human cells

For example, researchers have demonstrated that SBDS-dependent hypersensitivity to UV irradiation is distinct from its role in translation by comparing the effects of SBDS depletion with multiple methods of impairing global translation .

What are the challenges in studying SBDS due to its multiple functions?

Studying SBDS presents several methodological challenges:

  • Pleiotropic effects: SBDS mutations cause diverse phenotypes across multiple tissues, making it difficult to isolate specific functions

  • Essential gene: Complete loss of SBDS is lethal in mice, limiting certain experimental approaches

  • Species specificity: SBDS orthologs function in species-specific manners, limiting the utility of model organisms

  • Overlapping pathways: SBDS functions in interconnected cellular processes (ribosome biogenesis, DNA repair, stress response), making it difficult to separate primary from secondary effects

  • Genetic redundancy: Other genes (DNAJC21, EFL1, SRP54) can cause similar phenotypes, suggesting potential functional overlap that can complicate analysis

To address these challenges, researchers often employ a combination of approaches, including patient-derived cells, targeted mutation analysis, and comparative studies across different cellular contexts.

What is the relationship between SBDS mutations and myeloid neoplasia risk?

Shwachman-Diamond syndrome patients have a 10-30% risk of transformation to myeloid neoplasia, including myelodysplastic syndrome and acute myeloid leukemia . Among the genes associated with Shwachman-Diamond-like syndromes (SBDS, DNAJC21, EFL1, and SRP54), three have been linked to myeloid neoplasia: SBDS, DNAJC21, and SRP54 .

The molecular basis for this increased leukemia predisposition likely involves:

  • Impaired ribosome biogenesis leading to cellular stress

  • Compromised DNA damage response capabilities

  • Altered hematopoietic stem cell functions and bone marrow microenvironment

Understanding the specific mechanisms through which SBDS mutations contribute to leukemogenesis is crucial for developing targeted interventions and risk stratification approaches for SDS patients.

Product Science Overview

Introduction

Shwachman-Bodian-Diamond Syndrome (SBDS), also known as Shwachman-Diamond Syndrome (SDS), is a rare autosomal recessive disorder characterized by exocrine pancreatic insufficiency, bone marrow dysfunction, and skeletal abnormalities. It is caused by mutations in the SBDS gene, which is located on the long arm of chromosome 7 at cytogenetic position 7q11 .

Genetic Basis

The SBDS gene is composed of five exons and has an associated mRNA transcript that is 1.6 kilobase pairs in length . Mutations in this gene lead to a loss of function, resulting in the clinical manifestations of the syndrome. The SBDS protein is involved in ribosome biogenesis and cellular stress responses .

Clinical Features

The clinical features of SBDS are diverse and can vary significantly among affected individuals. The three major clinical features are:

  1. Peripheral Blood Cytopenia: This includes neutropenia, anemia, and thrombocytopenia. Neutropenia is the most common hematological finding and can be intermittent or persistent, leaving patients at risk of severe recurrent infections .
  2. Exocrine Pancreatic Dysfunction: This arises due to a lack of acinar cells that produce digestive enzymes, leading to malabsorption and failure to thrive .
  3. Skeletal Abnormalities: These include metaphyseal dysostosis, thoracic dystrophy, and costochondral thickening. Growth retardation is also common, with more than 50% of patients being below the third percentile for height .
Epidemiology

SBDS is a rare disorder with an estimated incidence of 1 in 122,600 live births . The male-to-female ratio is approximately 1.3:1 . The median age of onset is 0.16 years, but the diagnostic age often lags by a median of 1.3 years .

Diagnosis

Diagnosis of SBDS is based on clinical features and genetic testing. The detection rate of SBDS mutations is high, with approximately 94.6% of patients having identifiable mutations . Early diagnosis is crucial for effective management and intervention.

Treatment and Management

There is no cure for SBDS, and treatment is primarily supportive. Management includes:

  • Hematological Support: Regular monitoring of blood counts and treatment of infections.
  • Pancreatic Enzyme Replacement Therapy: To aid in digestion and improve nutritional status.
  • Growth Hormone Therapy: In some cases, to address growth retardation.
  • Bone Marrow Transplantation: For patients with severe bone marrow failure or those who develop hematologic malignancies .
Prognosis

The prognosis for individuals with SBDS varies. While some patients may have a relatively normal lifespan with appropriate medical care, others may experience severe complications, including bone marrow failure and transformation to acute myelogenous leukemia .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.